Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:526909rdf:typepubmed:Citationlld:pubmed
pubmed-article:526909lifeskim:mentionsumls-concept:C0459471lld:lifeskim
pubmed-article:526909lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:526909lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:526909lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:526909lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:526909lifeskim:mentionsumls-concept:C1521828lld:lifeskim
pubmed-article:526909lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:526909lifeskim:mentionsumls-concept:C1548818lld:lifeskim
pubmed-article:526909pubmed:issue11-12lld:pubmed
pubmed-article:526909pubmed:dateCreated1980-4-17lld:pubmed
pubmed-article:526909pubmed:abstractTextA statistical method for interpreting data on the efficacy of anticancer agents is proposed. Tables were prepared for the retrospective analysis of studies evaluating the activity of anticancer agents against individual tumor types. The number of responding patients and the number of patients entered in the study were used to more objectively and formally determine the future disposition of the drug. Several examples of clinical studies show that use of our tables allows a more satisfactory and reliable classification than is often currently reported.lld:pubmed
pubmed-article:526909pubmed:languageenglld:pubmed
pubmed-article:526909pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:526909pubmed:citationSubsetIMlld:pubmed
pubmed-article:526909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:526909pubmed:statusMEDLINElld:pubmed
pubmed-article:526909pubmed:issn0361-5960lld:pubmed
pubmed-article:526909pubmed:authorpubmed-author:RozencweigMMlld:pubmed
pubmed-article:526909pubmed:authorpubmed-author:SimonRRlld:pubmed
pubmed-article:526909pubmed:authorpubmed-author:BonoV HVHJrlld:pubmed
pubmed-article:526909pubmed:authorpubmed-author:MuggiaF MFMlld:pubmed
pubmed-article:526909pubmed:authorpubmed-author:StaquetM JMJlld:pubmed
pubmed-article:526909pubmed:authorpubmed-author:CataneRRlld:pubmed
pubmed-article:526909pubmed:authorpubmed-author:LeeY JYJlld:pubmed
pubmed-article:526909pubmed:issnTypePrintlld:pubmed
pubmed-article:526909pubmed:volume63lld:pubmed
pubmed-article:526909pubmed:ownerNLMlld:pubmed
pubmed-article:526909pubmed:authorsCompleteYlld:pubmed
pubmed-article:526909pubmed:pagination1713-20lld:pubmed
pubmed-article:526909pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:526909pubmed:meshHeadingpubmed-meshheading:526909-H...lld:pubmed
pubmed-article:526909pubmed:meshHeadingpubmed-meshheading:526909-N...lld:pubmed
pubmed-article:526909pubmed:meshHeadingpubmed-meshheading:526909-S...lld:pubmed
pubmed-article:526909pubmed:meshHeadingpubmed-meshheading:526909-F...lld:pubmed
pubmed-article:526909pubmed:meshHeadingpubmed-meshheading:526909-M...lld:pubmed
pubmed-article:526909pubmed:meshHeadingpubmed-meshheading:526909-A...lld:pubmed
pubmed-article:526909pubmed:meshHeadingpubmed-meshheading:526909-R...lld:pubmed
pubmed-article:526909pubmed:meshHeadingpubmed-meshheading:526909-D...lld:pubmed
pubmed-article:526909pubmed:articleTitleAnalysis and interpretation of response rates for anticancer drugs.lld:pubmed
pubmed-article:526909pubmed:publicationTypeJournal Articlelld:pubmed